Advice choosing a specialty

[pharmacy7424]

Advertisement - Members don't see this ad

Hello,

I need to choose a specialty for the summer at an major hospital that I will be interning at. My options are:

Anticoagulation
Infectious Disease
Medication Safety
Research on cost-effective treatment on critically ill patients

I am looking for serious advice on what will area will be the most practically helpful for obtaining an entry level position in some type of inpatient setting without a residency upon graduation. Thank you.

 

[SpirivaSunrise]

Hello,

I need to choose a specialty for the summer at an major hospital that I will be interning at. My options are:

Anticoagulation
Infectious Disease
Medication Safety
Research on cost-effective treatment on critically ill patients

I am looking for serious advice on what will area will be the most practically helpful for obtaining an entry level position in some type of inpatient setting without a residency upon graduation. Thank you.

# 4 gets my vote

 

[Praziquantel86]

Hello,

I need to choose a specialty for the summer at an major hospital that I will be interning at. My options are:

Anticoagulation
Infectious Disease
Medication Safety
Research on cost-effective treatment on critically ill patients

I am looking for serious advice on what will area will be the most practically helpful for obtaining an entry level position in some type of inpatient setting without a residency upon graduation. Thank you.

Without a residency, I think anticoagulation would be a good bet. Staffers are frequently enlisted to help with anticoagulation monitoring services, and having that background might make you more desirable. Medication safety would be very useful if you were looking towards a more administrative role, as would research. Infectious disease is more specialized, requiring some form of specialty training to make you marketable.

That being said, why not a residency?

 

[Its Z]

You left out the most important skill
How to impress your ceo with your mad ninja like golf skills

 

[njac]

I was thinking Med Safety.

 

[Its Z]

Get creative combine all 4 project into 1.

 

[psychoandy]

Anticoag and ID you can learn in class and APPEs.

I vote med safety or cost management. Why?
-Med safety is incredibly important and a growing field that pharmacy school totally neglects...and so is cost savings for that matter
-To understand both, you need to understand inpatient operations
-Most students/residents find these areas incredibly boring as they are more administrative, thus making you stand out.

Actually, I like combining all 4. Do 2 projects, appropriate use of direct thrombin inhibitors (DTIs are expensive and have huge safety issues and are anticoagulants) and evaluation of linezolid vs vancomycin for VAP (ID, cost difference vs efficacy, and ZEPHYR trial should be out by then)...it'd be fabulous and would look great for residency!

 

[Its Z]

Unfortunately zephyr same crap different day

Same pfizer paid kollef and wumderink gang. And same vanc 1 gram q 12 hours. Trash it already. Torezolid will kill zyvox.

 

[janeno]

I would go with ID but that's because all the other areas sound extremely boring to me.

 

[Praziquantel86]

Unfortunately zephyr same crap different day

Same pfizer paid kollef and wumderink gang. And same vanc 1 gram q 12 hours. Trash it already. Torezolid will kill zyvox.

You think? For quick treatments it looks like it might be the better drug, but I'd like to know more about the side effect profile. I think that tighter binding to the 23s would lead to tighter binding to the mitochondria - worsened neuropathy/thrombocytopenia/lactic acidosis...

 

[Its Z]

You think? For quick treatments it looks like it might be the better drug, but I'd like to know more about the side effect profile. I think that tighter binding to the 23s would lead to tighter binding to the mitochondria - worsened neuropathy/thrombocytopenia/lactic acidosis...

Good point of course. Safety profile study shows a similiar SAE profile compared to Linezolid. But n=8, it means nothing today.

I will be following this one closely because it has a huge $Stock$ implications like MNTA and OPTR... similarities in that their main study drug is their first drug looking for an FDA approval.

Efficacy looks good. Safety will determine its approval, or not.

We're 2 to 3 years away.